S1PR1 and Stroke: Combined with previous reports on the efficacy of S1PR modulators in the neuroinflammatory response and neurologic function after stroke [36, 90, 92, 100], siponimod, a selective modulator of S1PR1/5, may serve as a valuable therapeutic agent for the treatment of ICH.